Today, AMP started an initial position totaling $12,495 in Redhill Biopharma (RDHL) by buying 1,279 shares at a price of $9.77. Redhill Biopharma is an Israeli based company developing orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases, including cancer.
Redhill has two marketed products, Donnatal® (a prescription oral adjunctive drug used in the treatment of IBS and acute enterocolitis) and EnteraGam® - a medical food intended for the dietary management of chronic diarrhea and loose stools. It's most advanced clinical assets are in migraines, h pylori infections, gastritis, and Crohn's disease.